Literature DB >> 14564716

Brain ceramide hexosides in Tay-Sachs disease and generalized gangliosidosis (GM1-gangliosidosis).

K Suzuki1, G C Chen.   

Abstract

The carbohydrate composition was determined for ceramide hexosides isolated from brains of patients with Tay-Sachs disease and generalized gangliosidosis (hereby named GM1-gangliosidosis). Gray matter of patients with each disease showed a characteristic abnormal ceramide hexoside pattern. In Tay-Sachs gray matter, ceramide trihexoside is the major component, whereas ceramide tetrahexoside is barely detectable. In GM1-gangliosidosis, ceramide tetrahexoside is the major ceramide hexoside, while ceramide trihexoside is present only in small amount. These two major components have been characterized as the asialo derivatives of, respectively, the "Tay-Sachs ganglioside" (GM2-ganglioside) and the normal major monosialoganglioside (GM1-ganglioside). In both diseases, more than half the ceramide monohexoside of gray matter was glucocerebroside. Gray matter ceramide dihexoside, present in both diseases at higher than normal levels, was mostly ceramide lactoside, with possibly a small amount of ceramide digalactoside. Sulfatide contained only galactose. The abnormal ceramide hexoside pattern is limited to gray matter: white matter showed normal ceramide hexosides, i.e. a preponderance of monohexosides and sulfatide, with no detectable glucocerebroside.

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 14564716

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  18 in total

Review 1.  Progress in investigations of sphingolipidoses.

Authors:  M Adachi; L Schneck; B W Volk
Journal:  Acta Neuropathol       Date:  1978-08-07       Impact factor: 17.088

Review 2.  Mucopolysaccharidoses and mucolipidoses.

Authors:  F Van Hoof
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974

3.  Late onset GM2-gangliosidosis. Clinical, pathological, and biochemical studies on 8 patients.

Authors:  E M Brett; R B Ellis; L Haas; J U Ikonne; B D Lake; A D Patrick; R Stephens
Journal:  Arch Dis Child       Date:  1973-10       Impact factor: 3.791

4.  Glycolipids of hamster fibroblasts and derived malignant-transformed cell lines.

Authors:  S I Hakomori; W T Murakami
Journal:  Proc Natl Acad Sci U S A       Date:  1968-01       Impact factor: 11.205

5.  The genetic mucolipidoses. Diagnosis and differential diagnosis.

Authors:  J W Spranger; H R Wiedemann
Journal:  Humangenetik       Date:  1970

6.  Globoid cell leukodystrophy: deficiency of lactosyl ceramide beta-galactosidase.

Authors:  D A Wenger; M Sattler; W Hiatt
Journal:  Proc Natl Acad Sci U S A       Date:  1974-03       Impact factor: 11.205

7.  Mouse brain gangliosides. Their property of inhibiting EEE virus hemagglutination.

Authors:  M T Zapata; S Paglini
Journal:  Arch Gesamte Virusforsch       Date:  1973

8.  In vivo studies on ganglioside metabolsim.

Authors:  J N Kanfer; D A Ellis
Journal:  Lipids       Date:  1971-12       Impact factor: 1.880

9.  Chemical studies on postmortem tissues from an infant with a sphingomyelin storage disorder.

Authors:  S F Donaghey; D N Raine; J E Crossley
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

10.  Differential activities of glycolipid glycosyltransferases in Tay-Sachs disease: studies in cultured cells from cerebrum.

Authors:  M Basu; K A Presper; S Basu; L M Hoffman; S E Brooks
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.